<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="2663">Amiodarone</z:chebi> is a widely used antiarrythmic drug for various atrial and <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>It has the potential to cause prolongation of the QT interval, which, in turn, can increases the incidence of <z:hpo ids='HP_0001664'>torsade de pointes</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="2663">Amiodarone</z:chebi> is also one of the causes of prominent U waves </plain></SENT>
<SENT sid="3" pm="."><plain>The presented case exemplifies the phenomenon of <z:chebi fb="0" ids="2663">amiodarone</z:chebi>-induced T-U fusion and QT prolongation </plain></SENT>
<SENT sid="4" pm="."><plain>Other causes of QT prolongation as electrolyte abnormalities or administration of other drugs that prolong the QT interval were excluded </plain></SENT>
<SENT sid="5" pm="."><plain>Awareness of this phenomenon and method of calculation of QT interval in this scenario is of utmost importance </plain></SENT>
</text></document>